Cargando…

Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment

COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term m...

Descripción completa

Detalles Bibliográficos
Autores principales: Turégano-Yedro, Miguel, Trillo-Calvo, Eva, Navarro i Ros, Fernando, Maya-Viejo, José David, González Villaescusa, Cruz, Echave Sustaeta, Jose Maria, Doña, Esperanza, Alcázar Navarrete, Bernardino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697822/
http://dx.doi.org/10.2147/COPD.S431829
_version_ 1785154815668518912
author Turégano-Yedro, Miguel
Trillo-Calvo, Eva
Navarro i Ros, Fernando
Maya-Viejo, José David
González Villaescusa, Cruz
Echave Sustaeta, Jose Maria
Doña, Esperanza
Alcázar Navarrete, Bernardino
author_facet Turégano-Yedro, Miguel
Trillo-Calvo, Eva
Navarro i Ros, Fernando
Maya-Viejo, José David
González Villaescusa, Cruz
Echave Sustaeta, Jose Maria
Doña, Esperanza
Alcázar Navarrete, Bernardino
author_sort Turégano-Yedro, Miguel
collection PubMed
description COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term mortality. Factors that impact adherence are multiple, some related to patient, some related to clinicians and finally some related to healthcare system. Among clinician factors, prescription of simplified treatment regimens delivered by an inhaler adapted to the patient’s characteristics is crucial. Although it has been observed a huge improvement in the design and usability of inhaler devices for COPD in the last two centuries, there is still a clear gap in this field. Smart inhalers as well as simplified treatment regimens could improve adherence and therefore improve long-term outcomes in COPD.
format Online
Article
Text
id pubmed-10697822
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106978222023-12-06 Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment Turégano-Yedro, Miguel Trillo-Calvo, Eva Navarro i Ros, Fernando Maya-Viejo, José David González Villaescusa, Cruz Echave Sustaeta, Jose Maria Doña, Esperanza Alcázar Navarrete, Bernardino Int J Chron Obstruct Pulmon Dis Review COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term mortality. Factors that impact adherence are multiple, some related to patient, some related to clinicians and finally some related to healthcare system. Among clinician factors, prescription of simplified treatment regimens delivered by an inhaler adapted to the patient’s characteristics is crucial. Although it has been observed a huge improvement in the design and usability of inhaler devices for COPD in the last two centuries, there is still a clear gap in this field. Smart inhalers as well as simplified treatment regimens could improve adherence and therefore improve long-term outcomes in COPD. Dove 2023-12-04 /pmc/articles/PMC10697822/ http://dx.doi.org/10.2147/COPD.S431829 Text en © 2023 Turégano-Yedro et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Turégano-Yedro, Miguel
Trillo-Calvo, Eva
Navarro i Ros, Fernando
Maya-Viejo, José David
González Villaescusa, Cruz
Echave Sustaeta, Jose Maria
Doña, Esperanza
Alcázar Navarrete, Bernardino
Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
title Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
title_full Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
title_fullStr Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
title_full_unstemmed Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
title_short Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
title_sort inhaler adherence in copd: a crucial step towards the correct treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697822/
http://dx.doi.org/10.2147/COPD.S431829
work_keys_str_mv AT tureganoyedromiguel inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT trillocalvoeva inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT navarroirosfernando inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT mayaviejojosedavid inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT gonzalezvillaescusacruz inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT echavesustaetajosemaria inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT donaesperanza inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment
AT alcazarnavarretebernardino inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment